Miracle Mile Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Buy |
42,636
+2,366
| +6% | +$165K | 0.05% | 212 |
|
|
2025
Q1 | $2.96M | Buy |
40,270
+284
| +0.7% | +$20.9K | 0.06% | 177 |
|
|
2024
Q4 | $2.62M | Buy |
39,986
+32,659
| +446% | +$2.14M | 0.05% | 194 |
|
|
2024
Q3 | $571K | Sell |
7,327
-998
| -12% | -$77.8K | 0.01% | 351 |
|
|
2024
Q2 | $649K | Buy |
8,325
+711
| +9% | +$55.5K | 0.02% | 320 |
|
|
2024
Q1 | $516K | Buy |
7,614
+572
| +8% | +$38.8K | 0.01% | 345 |
|
|
2023
Q4 | $474K | Sell |
7,042
-32,978
| -82% | -$2.22M | 0.01% | 345 |
|
|
2023
Q3 | $2.71M | Sell |
40,020
-500
| -1% | -$33.9K | 0.08% | 144 |
|
|
2023
Q2 | $2.9M | Buy |
40,520
+600
| +2% | +$42.9K | 0.09% | 146 |
|
|
2023
Q1 | $2.77M | Hold |
39,920
| – | – | 0.09% | 156 |
|
|
2022
Q4 | $2.71M | Buy |
39,920
+1,373
| +4% | +$93.1K | 0.09% | 166 |
|
|
2022
Q3 | $2.11M | Sell |
38,547
-318
| -0.8% | -$17.4K | 0.1% | 142 |
|
|
2022
Q2 | $2.57M | Sell |
38,865
-14
| -0% | -$925 | 0.12% | 128 |
|
|
2022
Q1 | $2.58M | Buy |
38,879
+35,003
| +903% | +$2.32M | 0.11% | 135 |
|
|
2021
Q4 | $226K | Buy |
+3,876
| New | +$226K | 0.01% | 414 |
|